In the News

Revolutionizing Vaccine Adjuvants: A Journey with Botanical Solution Inc. and Quillaja Saponaria Trees

Posted: April 2024

Production of tree-saving transformative vaccine adjuvant with in-lab plants

Posted: April 2024

Q&A: Botanical Solutions’ Gaston Salinas champions pharma sustainability

Posted: November 2023

BSI wins “2023 Best Sustainable Product/Service of the Year” at UK’s Big Sustainability Awards

Posted: November 2023

BSI honored as Startup of the Month. CEO Gaston Salinas also honored as Founder of the Month

Posted: November 2023

BSI wins ICIS Chemical Business 2023 Best Process Innovation Award

Posted: October 2023

Botanical Solutions Inc. sees growth, recognition, in biologicals

Posted: October 2023

Botanical Solution Series A funding expands to $13 million

Posted: September 2023

Untapping the potential of saponin based vaccine adjuvants

Posted: June 2023

Croda, BSI partner on sustainable vaccine adjuvant QS-21

Posted: May 2023

Croda and BSI partner to fast-track sustainable vaccine adjuvant QS-21 production

Posted: May 2023

Quillibrium® wins Crop Science Award for “Best New Biological Product (Biopesticide)”

Posted: November 2022

Interview with Diego Ibanez, CFO Botanical Solution, Inc.

Posted: August 2022

Adjuvant from baby trees

Posted: June 2022

BSI wins Best Biotech Startup Business of the Year 2022 Award

Posted: May 2022

BSI gains new funding and expands to more countries with new approach to disease control

Posted: February 2022

Empresa chilena de biotecnología en base a quillay obtiene más de US$ 6 millones en financiamiento

Posted: January 2022

Quillay chileno en los ojos de Palo Alto

Posted: January 2022

Innovation grows on trees

Posted: May 2021

Plant-derived fungicide finds larger market

Posted: April 2021